Identification of Potential Predictors of Prognosis and Sorafenib-Associated Survival Benefits in Patients with Hepatocellular Carcinoma after Transcatheter Arterial Chemoembolization

Some studies have shown that sorafenib could significantly prolong the overall survival of patients with unresectable hepatocellular carcinoma treated with transcatheter arterial chemoembolization (TACE). However, other studies revealed that patients had no access to sorafenib-related survival benef...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Kun He, Zelong Yang, Xinyu Liu, Yanling Yang, Wenjie Song, Shangyu Wang, Yong Chen
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2022-12-01
coleção:	Current Oncology
Assuntos:	predictors hepatocellular carcinoma vascular endothelial growth factor transcatheter arterial chemoembolization sorafenib
Acesso em linha:	https://www.mdpi.com/1718-7729/30/1/38
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!